Breaking News, Collaborations & Alliances

Ajinomoto Bio-Pharma Partners with Humanigen

Signs manufacturing agreement for Lenzilumab, a monoclonal antibody

By: Contract Pharma

Contract Pharma Staff

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, has entered into a manufacturing agreement with Humanigen Inc., for the fill finish supply of lenzilumab, currently being studied in a Phase III clinical trial in adult, hospitalized patients with COVID-19.   “We are extremely pleased to partner with Humanigen in the fight against COVID-19 and to use our unique position as a US-based manufacturer to help simplify and secure a key...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters